| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/JCN.0B013E3181E0F881 |
| P953 | full work available at URL | http://content.wkhealth.com/linkback/openurl?issn=0889-4655&volume=25&issue=6&spage=E1 |
| https://journals.lww.com/10.1097/JCN.0b013e3181e0f881 | ||
| P698 | PubMed publication ID | 20938245 |
| P2093 | author name string | Ingela Johansson | |
| Anna Strömberg | |||
| P2860 | cites work | Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction | Q28208692 |
| Resumption of driving after life-threatening ventricular tachyarrhythmia | Q33146680 | ||
| Syncope, driving recommendations, and clinical reality: survey of patients | Q33148460 | ||
| Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Ther | Q33151960 | ||
| Addendum to "Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations: a medical/scientific statement from the American Heart Association and the North American | Q33154785 | ||
| Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study | Q33156522 | ||
| Recurrent cardiac events in survivors of ventricular fibrillation or tachycardia. Implications for driving restrictions | Q33174152 | ||
| Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations. A medical/scientific statement from the American Heart Association and the North American Society of P | Q33174830 | ||
| Driving issues related to arrhythmic syncope | Q33175202 | ||
| Syncope in patients with an implantable cardioverter-defibrillator: incidence, prediction and implications for driving restrictions | Q33175534 | ||
| Mechanisms of syncope in implantable cardioverter-defibrillator recipients who receive device therapies | Q33175900 | ||
| Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure | Q34321811 | ||
| Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure | Q34386004 | ||
| Applying phenomenography in nursing research | Q34969907 | ||
| Understanding implantable cardioverter defibrillator shocks and storms: medical and psychosocial considerations for research and clinical care. | Q35103254 | ||
| Exploring the patient's experiences of learning to live with an implantable cardioverter defibrillator (ICD) from one UK centre: a qualitative study | Q40549022 | ||
| Recurrence of symptomatic ventricular arrhythmias in patients with implantable cardioverter defibrillator after the first device therapy: implications for antiarrhythmic therapy and driving restrictions. CARE Group | Q40703058 | ||
| Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators | Q44086151 | ||
| Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators | Q47635686 | ||
| Partners of ICD patients--an exploratory study of their experiences | Q48525618 | ||
| Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results from the TOVA study | Q50084690 | ||
| The psychosocial and physiological experiences of patients with an implantable cardioverter defibrillator | Q50111126 | ||
| Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. | Q50744359 | ||
| Modification of patient driving behavior after implantation of a cardioverter defibrillator. | Q50932719 | ||
| Time to resumption of driving after implantation of an automatic defibrillator (from the Dual chamber and VVI Implantable Defibrillator [DAVID] trial). | Q51538688 | ||
| How does an implantable cardioverter defibrillator (ICD) affect the lives of patients and their families? | Q52012897 | ||
| Factors related to driving in persons with an implantable cardioverter defibrillator. | Q52916529 | ||
| ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities | Q58972654 | ||
| ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiolog | Q58973358 | ||
| Recommendations for driving of patients with implantable cardioverter defibrillators. Study Group on 'ICD and Driving' of the Working Groups on Cardiac Pacing and Arrhythmias of the European Society of Cardiology | Q74152257 | ||
| Driving and heart disease | Q77309324 | ||
| Sudden death in patients with implantable cardioverter defibrillators: the importance of post-shock electromechanical dissociation | Q77947832 | ||
| Australian implantable cardiac defibrillator recipients: quality-of-life issues | Q78055238 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | defibrillator | Q1450682 |
| P304 | page(s) | E1-E10 | |
| P577 | publication date | 2010-11-01 | |
| P1433 | published in | Journal of Cardiovascular Nursing | Q3032138 |
| P1476 | title | Experiences of driving and driving restrictions in recipients with an implantable cardioverter defibrillator--the patient perspective | |
| Experiences of Driving and Driving Restrictions in Recipients With an Implantable Cardioverter Defibrillator-The Patient Perspective | |||
| P478 | volume | 25 |
| Q36828470 | "Are you still driving?" Metasynthesis of patient preferences for communication with health care providers |
| Q47318200 | "Hosting" an implantable cardioverter defibrillator: A phenomenological inquiry. |
| Q28087002 | 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of [...] |
| Q64074238 | A Review of Driving Restrictions in Patients at Risk of Syncope and Cardiac Arrhythmias Associated with Sudden Incapacity: Differing Global Approaches to Regulation and Risk |
| Q59330007 | Driving following defibrillator implantation: development and pilot results from a nationwide questionnaire |
| Q47278874 | Driving restrictions for Dutch patients with an implantable cardioverter defibrillator : Compliance and associated factors |
| Q47149520 | Driving restrictions in patients with implantable cardioverter defibrillators and pacemakers |
| Q47162927 | Evaluating the feasibility of conducting a trial using a patient decision aid in implantable cardioverter defibrillator candidates: a randomized controlled feasibility trial |
| Q38068334 | Incorporating the patient perspective: a critical review of clinical practice guidelines for implantable cardioverter defibrillator therapy |
| Q28072732 | Perceptions and experiences of patients living with implantable cardioverter defibrillators: a systematic review and meta-synthesis |
Search more.